Infinimmune vs Poplar Therapeutics
Infinimmune vs Poplar Therapeutics, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Infinimmune is on 60/100 and Poplar Therapeutics on 51/100.
Where each one leads
Infinimmune
- our overall score: 60/100 against 51/100
- domain rating: 20/100 against 4/100
- headcount: 22 against 15
- funding raised: $75.0M against $50.0M
- LinkedIn following: 4,055 against 1,205
Poplar Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Infinimmune | Poplar Therapeutics |
|---|---|---|
| What it is | Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms. | Developing a new class of anti-IgE therapy for multiple atopic conditions. |
| Category | Biotechnology, Pharmaceuticals, Artificial Intelligence, HealthTech | Biotechnology, Pharmaceuticals, HealthTech, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2017 | 2021 |
| Headquarters | Alameda, United States | Boston, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Infinimmune | Poplar Therapeutics |
|---|---|---|
| Employees | 22 | 15 |
| Total funding | $75.0M | $50.0M |
| Latest round | Series A | Series A |
| LinkedIn followers | 4,055 | 1,205 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Infinimmune | Poplar Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 51/100 |
| Traction | 53/100 | 51/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 23/100 | 25/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Infinimmune | Poplar Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Webflow | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4 |
Infinimmune vs Poplar Therapeutics: common questions
Which is better, Infinimmune or Poplar Therapeutics?
On our 0-100 score Infinimmune rates higher (60/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Infinimmune and Poplar Therapeutics compare on the numbers?
Infinimmune leads on our overall score (60/100 against 51/100), domain rating (20/100 against 4/100), headcount (22 against 15), funding raised ($75.0M against $50.0M), LinkedIn following (4,055 against 1,205).
Read the full Infinimmune review and pricing or the Poplar Therapeutics review and pricing. You can also browse other Infinimmune alternatives we track.